psychedelics

Why a Psychedelics Campaign in Washington State Stands Out

What comes next for the "psychedelic renaissance"? Massachusetts has a decriminalization and limited legalization measure on the November ballot. Comparable…

October 15, 2024

DEA Bids to Exclude Expert Witnesses From Psychedelics-Ban Hearing

The Drug Enforcement Administration is seeking to exclude what advocates say is key testimony from an upcoming hearing on the…

October 4, 2024

License Fees a Sticking Point as Colorado Plans Legal Psilocybin Services

The clock is ticking for legal psilocybin therapy to begin in Colorado. In 2022, voters approved Proposition 122, a measure…

October 3, 2024

Psychedelic-Climate Week Launches in NYC: What Are the Connections?

Psychedelic-Climate Week launched in Manhattan on September 17. Timed to run alongside the annual Climate Week NYC, with most events…

September 18, 2024

Psychedelic Advocates Air FDA Frustrations at Reagan-Udall Meeting

On September 6, the Reagan-Udall Foundation for the Food and Drug Administration, an independent nonprofit created by Congress in 2007…

September 9, 2024

Festival Drug Checking Services Still Too Often Sidelined

It’s a scorching July day in British Columbia, at Bass Coast festival, and there is no line outside the drug…

September 5, 2024

Basement “Psychedelic Church” Springs Up After Colorado Reform

“I found my peace through mushrooms about two and a half years ago,” Dez told Filter, after “I woke up…

September 5, 2024

DEA Schedules Historic Public Hearing on Psychedelics DOI, DOC

The Drug Enforcement Administration’s years-long campaign to ban two lesser-known psychedelic substances—2,5-Dimethoxy-4-iodoamphetamine (DOI) and 2,5-Dimethoxy-4-chloroamphetamine (DOC)—has faced consistent opposition from…

August 27, 2024

Olympia, WA, Decriminalizes Psychedelic Plants and Fungi

Leaders in Washington State’s capital city of Olympia voted unanimously on August 13 to pass a resolution locally decriminalizing psilocybin…

August 15, 2024

FDA Rejects MDMA Treatment for PTSD, Requesting Redo of Key Trial

The Food and Drug Administration has rejected a high-profile application for MDMA-assisted therapy to treat PTSD, citing insufficient data to…

August 12, 2024